Lipidil and Pain exacerbated - a phase IV clinical study of FDA data

Summary:

Pain exacerbated is reported as a side effect among people who take Lipidil (fenofibrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lipitor, and have High blood pressure.

The phase IV clinical study analyzes which people have Pain exacerbated when taking Lipidil. It is created by eHealthMe based on reports of 2,594 people who have side effects when taking Lipidil from the FDA, and is updated regularly.

What is Lipidil?

Lipidil has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 2,699 Lipidil users. Check the latest studies of Lipidil.

What is Pain exacerbated?

Pain exacerbated is found to be associated with 3,981 drugs and 3,025 conditions by eHealthMe. Check the latest studies of Pain exacerbated.

On Jul, 20, 2026

2,594 people reported to have side effects when taking Lipidil.
Among them, 92 people (3.55%) have Pain exacerbated.

Among these 92 people:

How long have people been on Lipidil when they have Pain exacerbated? *

What is the gender of people who have Pain exacerbated when taking Lipidil? *

female: 48.86 %
male: 51.14 %

What is the age of people who have Pain exacerbated when taking Lipidil? *

What are other drugs people take besides Lipidil? *

What are other side effects people have besides Pain exacerbated? *

High Blood Pressure: 30 people, 32.61%
Dizziness: 26 people, 28.26%
Body Temperature Decreased: 23 people, 25.00%
Drug Ineffective: 23 people, 25.00%
Pain In Extremity: 23 people, 25.00%
Heart Rate Decreased: 22 people, 23.91%
Weakness: 22 people, 23.91%
Back Pain: 22 people, 23.91%
Diarrhea: 21 people, 22.83%
Nausea (feeling of having an urge to vomit): 21 people, 22.83%

What are the existing conditions these people have? *

High Blood Pressure: 16 people, 17.39%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 16.30%
Zollinger-Ellison Syndrome (increased production of the hormone gastrin from a small tumour of pancreas): 14 people, 15.22%
Hyperlipidaemia (presence of excess lipids in the blood): 9 people, 9.78%
Carcinoid Tumor: 6 people, 6.52%
Diabetes: 6 people, 6.52%
Type 2 Diabetes: 6 people, 6.52%
Neuropathy Peripheral (surface nerve damage): 5 people, 5.43%
Arrhythmias (irregular heartbeat): 5 people, 5.43%
Enlarged Heart: 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Lipidil and have Pain exacerbated?

- Check whether Pain exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lipidil:

Lipidil (2,699 reports)

Browse all side effects of Lipidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain exacerbated:

Pain exacerbated (3,981 drugs)

Browse all the conditions that are associated with Pain exacerbated:

Pain exacerbated (3,025 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Lipidil) and Lipidil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.